Differentiation of mouse embryonic stem cells into growth hormone and prolactin expressing cells in vitro

Molecular and Cellular Endocrinology

Volumn 273, Issue 1-2, 2007, Pages 68-74

  Wagner, Josef ^a,b   Lepore, Diana ^a   Thomas, Paul ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Embryonic stem cells; Growth hormone; Pituitary; Prolactin

Indexed keywords

GROWTH HORMONE; HYPOPHYSIS HORMONE; PROLACTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL POPULATION; CELL TYPE; CELL VIABILITY; EMBRYONIC STEM CELL; GENE INDUCTION; GROWTH HORMONE SECRETING CELL; HORMONE RELEASE; HYPOPHYSIS; IMMUNOREACTIVITY; IN VITRO STUDY; MESODERM; MOUSE; NEUROECTODERM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GROWTH HORMONE; IMMUNOHISTOCHEMISTRY; MICE; PROLACTIN;

EID: 34347397841     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.05.007     Document Type: Article

References (33)

1. Bryant J., Cave C., Mihaylova B., Chase D., McIntyre L., Gerard K., and Milne R. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol. Assess. 6 (2002) 1-168
2. Bryant J., Loveman E., Chase D., Mihaylova B., Cave C., Gerard K., and Milne R. Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation. Health Technol. Assess. 6 (2002) 1-106
3. Cohen L.E., and Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr. Rev. 23 (2002) 431-442
4. Delhase M., Rajas F., Verdood P., Remy C., Chevallier P., Velkeniers B., Trouillas J., and Hooghe-Peters E.L. Prolactin and growth hormone mRNA and protein characterization in SMtTW rat pituitary tumours. J. Mol. Endocrinol. 15 (1995) 233-243
5. Ericson J., Norlin S., Jessell T.M., and Edlund T. Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 125 (1998) 1005-1015
6. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
7. Herlant M. The cells of the adenohypophysis and their functional significance. Int. Rev. Cytol. 17 (1964) 299-382
8. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19 (2005) 1129-1155
9. Keller G.M. In vitro differentiation of embryonic stem cells. Curr. Opin. Cell Biol. 7 (1995) 862-869
10. Knowles B.B., Howe C.C., and Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209 (1980) 497-499
11. Li S., Crenshaw III E.B., Rawson E.J., Simmons D.M., Swanson L.W., and Rosenfeld M.G. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347 (1990) 528-533
12. Lumelsky N., Blondel O., Laeng P., Velasco I., Ravin R., and McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292 (2001) 1389-1394
13. Magoulas C., McGuinness L., Balthasar N., Carmignac D.F., Sesay A.K., Mathers K.E., Christian H., Candeil L., Bonnefont X., Mollard P., and Robinson I.C. A secreted fluorescent reporter targeted to pituitary growth hormone cells in transgenic mice. Endocrinology 141 (2000) 4681-4689
14. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 7634-7638
15. Nagy A.G.M., Vintersten K., and Behringer R. In Manipulation the Mouse Embryo (2003), Cold Spring Harbor, New York
16. Nasonkin I.O., Ward R.D., Raetzman L.T., Seasholtz A.F., Saunders T.L., Gillespie P.J., and Camper S.A. Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum. Mol. Genet. 13 (2004) 2727-2735
17. Nolan L.A., Kavanagh E., Lightman S.L., and Levy A. Anterior pituitary cell population control: basal cell turnover and the effects of adrenalectomy and dexamethasone treatment. J. Neuroendocrinol. 10 (1998) 207-215
18. Olson L.E., Tollkuhn J., Scafoglio C., Krones A., Zhang J., Ohgi K.A., Wu W., Taketo M.M., Kemler R., Grosschedl R., Rose D., Li X., and Rosenfeld M.G. Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell 125 (2006) 593-605
19. Pfaffle R., Kim C., Otten B., Wit J.M., Eiholzer U., Heimann G., and Parks J. Pit-1: clinical aspects. Horm. Res. 45 Suppl. 1 (1996) 25-28
20. Procter A.M., Phillips III J.A., and Cooper D.N. The molecular genetics of growth hormone deficiency. Hum. Genet. 103 (1998) 255-272
21. Rajagopal J., Anderson W.J., Kume S., Martinez O.I., and Melton D.A. Insulin staining of ES cell progeny from insulin uptake. Science 299 (2003) 363
22. Rathjen J., Haines B.P., Hudson K.M., Nesci A., Dunn S., and Rathjen P.D. Directed differentiation of pluripotent cells to neural lineages: homogeneous formation and differentiation of a neurectoderm population. Development 129 (2002) 2649-2661
23. Rathjen J., Lake J.A., Bettess M.D., Washington J.M., Chapman G., and Rathjen P.D. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J. Cell Sci. 112 Pt 5 (1999) 601-612
24. Shin S., Sun Y., Liu Y., Khaner H., Svant S., Cai J., Xu Q.X., Davidson B.P., Stice S.L., Smith A.K., Goldman S.A., Reubinoff B.E., Zhan M., Rao M.S., and Chesnut J.D. Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue. Stem Cells 25 (2007) 1298-1306
25. Sornson M.W., Wu W., Dasen J.S., Flynn S.E., Norman D.J., O'Connell S.M., Gukovsky I., Carriere C., Ryan A.K., Miller A.P., Zuo L., Gleiberman A.S., Andersen B., Beamer W.G., and Rosenfeld M.G. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384 (1996) 327-333
26. Tashjian Jr. A.H., Yasumura Y., Levine L., Sato G.H., and Parker M.L. Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82 (1968) 342-352
27. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
28. Treier M., Gleiberman A.S., O'Connell S.M., Szeto D.P., McMahon J.A., McMahon A.P., and Rosenfeld M.G. Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev. 12 (1998) 1691-1704
29. U H.S., Alilain W., and Saljooque F. Fetal brain progenitor cells transdifferentiate to fates outside the nervous system. Mol. Endocrinol. 16 (2002) 2645-2656
30. Wagner J., and Thomas P. Genetic determinants of mammalian pituitary morphogenesis. Front Biosci. 12 (2007) 125-134
31. Wu W., Cogan J.D., Pfaffle R.W., Dasen J.S., Frisch H., O'Connell S.M., Flynn S.E., Brown M.R., Mullis P.E., Parks J.S., Phillips III J.A., and Rosenfeld M.G. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat. Gen. 18 (1998) 147-149
32. Ying Q.L., Nichols J., Chambers I., and Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3 Cell vol.115 (2003) 281-292
33. Zhao X., Teng R., Asanuma K., Okouchi Y., Johkura K., Ogiwara N., and Sasaki K. Differentiation of mouse embryonic stemc ells into gonadotrope-like cells in vitro. J. Soc. Gynecol. Invest. 12 (2005) 257-262